“Short-term Outcomes of the Use of Intraventricular Ribavirin in Filipino Patients with Subacute Sclerosing Panencephalitis”, Acta Med Philipp, vol. 56, no. 9, May 2022, doi: 10.47895/amp.v56i9.5341.